4ZU logo

Biora Therapeutics DB:4ZU Stock Report

Last Price

€5.10

Market Cap

€10.0m

7D

0%

1Y

-66.2%

Updated

05 Nov, 2024

Data

Company Financials +

Biora Therapeutics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Biora Therapeutics
Historical stock prices
Current Share PriceUS$5.10
52 Week HighUS$23.00
52 Week LowUS$3.88
Beta1.23
11 Month Change2.82%
3 Month Change-0.97%
1 Year Change-66.23%
33 Year Change-99.30%
5 Year Changen/a
Change since IPO-99.18%

Recent News & Updates

Recent updates

Shareholder Returns

4ZUDE BiotechsDE Market
7D0%0.8%-2.2%
1Y-66.2%-14.4%13.3%

Return vs Industry: 4ZU underperformed the German Biotechs industry which returned -14.4% over the past year.

Return vs Market: 4ZU underperformed the German Market which returned 13.3% over the past year.

Price Volatility

Is 4ZU's price volatile compared to industry and market?
4ZU volatility
4ZU Average Weekly Movement11.4%
Biotechs Industry Average Movement6.1%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 4ZU's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 4ZU's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
201058Adi Mohantywww.bioratherapeutics.com

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline.

Biora Therapeutics, Inc. Fundamentals Summary

How do Biora Therapeutics's earnings and revenue compare to its market cap?
4ZU fundamental statistics
Market cap€9.97m
Earnings (TTM)-€79.81m
Revenue (TTM)€790.68k

12.6x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4ZU income statement (TTM)
RevenueUS$860.00k
Cost of RevenueUS$0
Gross ProfitUS$860.00k
Other ExpensesUS$87.67m
Earnings-US$86.81m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-23.60
Gross Margin100.00%
Net Profit Margin-10,094.19%
Debt/Equity Ratio-53.0%

How did 4ZU perform over the long term?

See historical performance and comparison